ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CEPI and VBI to develop vaccines against SARS-CoV-2 variants pharmaceutical-technology
March 12, 2021The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines have entered a collaboration to advance the latter’s enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants.
Pharma Sources Insight January 2025
